U.S. Facial Injectable Market Size & Outlook, 2025-2030
Related Markets
U.S. facial injectable market highlights
- The U.S. facial injectable market generated a revenue of USD 4,265.7 million in 2024 and is expected to reach USD 8,015.6 million by 2030.
- The U.S. market is expected to grow at a CAGR of 11.2% from 2025 to 2030.
- In terms of segment, botulinum toxin type a was the largest revenue generating product in 2024.
- HA is the most lucrative product segment registering the fastest growth during the forecast period.
Facial injectable market data book summary
| Market revenue in 2024 | USD 4,265.7 million |
| Market revenue in 2030 | USD 8,015.6 million |
| Growth rate | 11.2% (CAGR from 2025 to 2030) |
| Largest segment | Botulinum toxin type a |
| Fastest growing segment | HA |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Collagen, Botulinum Toxin Type A, HA, CaHA, PLLA |
Other key industry trends
- In terms of revenue, U.S. accounted for 34.0% of the global facial injectable market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. facial injectable market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 8,015.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Facial Injectable Market Scope
Facial Injectable Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Galderma | View profile | 10001+ | Lausanne, Vaud, Switzerland, Europe | http://www.galderma.com |
| Medytox | View profile | 501-1000 | Seoul, Seoul-t'ukpyolsi, South Korea, Asia | http://www.medytox.com/page/company_en?site_id=en |
| Sinclair Pharma plc | View profile | 501-1000 | London, England, United Kingdom, Europe | http://www.sinclairpharma.com/ |
| Merz Pharma | View profile | 5001-10000 | Deutsch, Sachsen, Germany, Europe | http://www.merz.com |
| Revance Therapeutics Inc | View profile | 597 | 1222 Demonbreun Street, Suite 2000, Nashville, TN, United States, 37203 | https://www.revance.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
U.S. facial injectable market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to facial injectable market will help companies and investors design strategic landscapes.
Botulinum toxin type a was the largest segment with a revenue share of 60.45% in 2024. Horizon Databook has segmented the U.S. facial injectable market based on collagen, botulinum toxin type a, ha, caha, plla covering the revenue growth of each sub-segment from 2018 to 2030.
The US Facial Injectable Market is set for accelerated growth, driven by expanding regulatory approvals and innovation in aesthetic treatments. For instance, in October 2024, Allergan Aesthetics, an AbbVie company, received FDA approval for BOTOX Cosmetic to treat moderate to severe platysma bands, making it the first injectable with four aesthetic indications—forehead lines, frown lines, crow’s feet, and now neck rejuvenation.
This breakthrough expands the scope of non-surgical facial and neck treatments, addressing a growing consumer demand for comprehensive, minimally invasive aesthetic solutions. With BOTOX Cosmetic now extending beyond the face, the approval is expected to drive higher adoption rates and broaden the target patient base, further fueling the growth of the U.S. Facial Injectable Market.
Reasons to subscribe to U.S. facial injectable market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. facial injectable market databook
-
Our clientele includes a mix of facial injectable market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. facial injectable market , including forecasts for subscribers. This country databook contains high-level insights into U.S. facial injectable market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
US Product - Facial Injectable Market size, 2024 - 2030 (US$M)
U.S. Facial Injectable Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
